Increased AKT and mTOR phosphorylation was shown by Western blotting when SETDB1 was overexpressed in glioblastoma lines, and this effect was reversed by administration of MK-2206 (Fig. 5a and b). The gene discussed is SETDB1; the disease is glioblastoma.